Global GMP Leader Novell Pharmaceutical Laboratories holds EU, Australia, South Africa, GCC, UAE, Kenya, Turkey GMP approvals and has expanded with regional offices in the Philippines, Thailand, and Vietnam, signaling strong compliance and readiness to supply international markets. Leverage this credibility to pitch export partnerships, contract manufacturing, and co-development opportunities with regional distributors and hospitals.

Diversified Market Access With a strategic positioning as a local Indonesian company offering high-value, affordable alternatives to imported medicines, Novell can be targeted for regional procurement deals, public tenders, and government-backed programs seeking cost-effective healthcare solutions in Southeast Asia and beyond.

Growing Revenue Opportunity Current revenue range of $250M-$500M indicates a sizeable sales base and capacity to scale. Engage in upsell of injectable and high-margin products, expansion of contract manufacturing services, and partnerships to accelerate new product introductions under licensing or co-branding agreements.

Technology and Design Investments in design and engineering tools (Adobe Creative Suite, AutoCAD, jQuery, CSS, Microsoft Project) suggest strong capabilities in product packaging, regulatory submissions, and project management. Use this to position services around regulatory documentation, GMP-compliant packaging optimization, and virtual design-to-market timelines for new products.

Strategic Partnerships Active pursuit of partnerships to market novel products mirrors opportunities to collaborate with multinational pharma firms for licensing, distribution, or joint ventures. Propose a structured collaboration framework focused on portfolio expansion, regional market entry, and shared manufacturing capacity to accelerate growth.